5-aminolevulinic acid induced photodynamic reactions in diagnosis and therapy for female lower genital tract diseases
- PMID: 39076768
- PMCID: PMC11284047
- DOI: 10.3389/fmed.2024.1370396
5-aminolevulinic acid induced photodynamic reactions in diagnosis and therapy for female lower genital tract diseases
Abstract
Since the patients suffering from female lower genital tract diseases are getting younger and younger and the human papilloma virus (HPV) infection is becoming more widespread, the novel non-invasive precise modalities of diagnosis and therapy are required to remain structures of the organ and tissue, and fertility as well, by which the less damage to normal tissue and fewer adverse effects are able to be achieved. In all nucleated mammalian cells, 5-Aminolevulinic acid (5-ALA) is an amino acid that occurs spontaneously, which further synthesizes in the heme biosynthetic pathway into protoporphyrin IX (PpIX) as a porphyrin precursor and photosensitizing agent. Exogenous 5-ALA avoids the rate-limiting step in the process, causing PpIX buildup in tumor tissues. This tumor-selective PpIX distribution after 5-ALA application has been used successfully for tumor photodynamic diagnosis (PDD) and photodynamic therapy (PDT). Several ALA-based drugs have been used for ALA-PDD and ALA-PDT in treating many (pre)cancerous diseases, including the female lower genital tract diseases, yet the ALA-induced fluorescent theranostics is needed to be explored further. In this paper, we are going to review the studies of the mechanisms and applications mainly on ALA-mediated photodynamic reactions and its effectiveness in treating female lower genital tract diseases.
Keywords: 5-aminolaevulinic acid; HPV infection; female lower genital tract diseases; photodynamic diagnosis; photodynamic therapy.
Copyright © 2024 Chen, Guo, Chen and He.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.Bioengineering (Basel). 2023 Apr 21;10(4):496. doi: 10.3390/bioengineering10040496. Bioengineering (Basel). 2023. PMID: 37106683 Free PMC article. Review.
-
Efficacy of 5-Aminolevulinic Acid in Photodynamic Detection and Photodynamic Therapy in Veterinary Medicine.Cancers (Basel). 2019 Apr 7;11(4):495. doi: 10.3390/cancers11040495. Cancers (Basel). 2019. PMID: 30959982 Free PMC article.
-
5-Aminolevulinic-acid-mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Metastases in Biliary Tract Cancer in Mice.In Vivo. 2017 Sep-Oct;31(5):905-908. doi: 10.21873/invivo.11145. In Vivo. 2017. PMID: 28882957 Free PMC article.
-
Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review.Cancer Lett. 2020 Oct 10;490:165-173. doi: 10.1016/j.canlet.2020.06.008. Epub 2020 Jun 10. Cancer Lett. 2020. PMID: 32534172 Review.
-
The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.Photodiagnosis Photodyn Ther. 2013 Dec;10(4):399-409. doi: 10.1016/j.pdpdt.2013.03.003. Epub 2013 Apr 12. Photodiagnosis Photodyn Ther. 2013. PMID: 24284092
Cited by
-
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy.Cells. 2024 Nov 20;13(22):1924. doi: 10.3390/cells13221924. Cells. 2024. PMID: 39594672 Free PMC article. Review.
References
-
- Hagiya Y, Endo Y, Yonemura Y, Takahashi K, Ishizuka M, Abe F, et al. . Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro. Photodiagn Photodyn Ther. (2012) 9:204–14. doi: 10.1016/j.pdpdt.2011.12.004 - DOI - PubMed
-
- Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ, et al. . Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. (2000) 93:1003–13. doi: 10.3171/jns.2000.93.6.1003 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources